Abstract
Upscaling of kidney epithelial cells is crucial for renal regenerative medicine. Nonetheless, the adult kidney lacks a distinct stem cell hierarchy, limiting the ability to long-term propagate clonal populations of primary cells that retain renal identity. Toward this goal, we tested the paradigm of shifting the balance between differentiation and stemness in the kidney by introducing a single pluripotency factor, OCT4. Here we show that ectopic expression of OCT4 in human adult kidney epithelial cells (hKEpC) induces the cells to dedifferentiate, stably proliferate, and clonally emerge over many generations. Control hKEpC dedifferentiate, assume fibroblastic morphology, and completely lose clonogenic capacity. Analysis of gene expression and histone methylation patterns revealed that OCT4 represses the HNF1B gene module, which is critical for kidney epithelial differentiation, and concomitantly activates stemness-related pathways. OCT4-hKEpC can be long-term expanded in the dedifferentiated state that is primed for renal differentiation. Thus, when expanded OCT4-hKEpC are grown as kidney spheroids (OCT4-kSPH), they reactivate the HNF1B gene signature, redifferentiate, and efficiently generate renal structures in vivo. Hence, changes occurring in the cellular state of hKEpC following OCT4 induction, long-term propagation, and 3D aggregation afford rapid scale-up technology of primary renal tissue-forming cells.
Original language | English |
---|---|
Pages (from-to) | 329-346 |
Number of pages | 18 |
Journal | Molecular Therapy Methods and Clinical Development |
Volume | 29 |
DOIs | |
State | Published - 8 Jun 2023 |
Bibliographical note
Publisher Copyright:© 2023 The Authors
Funding
We wish to thank Prof. Zohar Dotan from the Department of Urology, Sheba Medical Center, Tel Hashomer, for providing human kidney tissue samples. The work is supported by ISF (Israel Science Foundation) grants 910/11 and 2071/17, the Israel Ministry of Industry “NOFAR” program, Wolfoson Clore Mayer, and the Sagol Center for Regenerative Medicine, School of Medicine, Tel Aviv University (B.D.); an NIH-NIDDK Diabetic Complications Pilot & Feasibility grant (DK076169), the NephroTools FP7 Marie Curie Initial Training Network (project 289754), and The Lisa and David Pulver Family Foundation (B.D.). E.M. is the Arthur Gutterman Family Chair for Stem Cell Research. This work was partially supported by a generous gift from Arthur Gutterman to E.M. and B.D. D.O. conducted and designed the experiments and wrote the paper, O.H.-S. conducted and designed the experiments, O.C.Z. performed bioinformation analysis, O.P. wrote the paper, Y.G. performed experiments and analysis, M.N. performed experiments and analysis, A.-H.C. performed experiments and analysis, M.N.-R. performed experiments and analysis, G.T. performed experiments and analysis, T.K. designed experiments and analysis, E.M. designed experiments and wrote the paper, and B.D. conducted and designed the experiments and wrote the paper. The authors declare no competing interests. We wish to thank Prof. Zohar Dotan from the Department of Urology, Sheba Medical Center, Tel Hashomer, for providing human kidney tissue samples. The work is supported by ISF (Israel Science Foundation) grants 910/11 and 2071/17 , the Israel Ministry of Industry “NOFAR” program, Wolfoson Clore Mayer , and the Sagol Center for Regenerative Medicine , School of Medicine , Tel Aviv University (B.D.); an NIH - NIDDK Diabetic Complications Pilot & Feasibility grant ( DK076169 ), the NephroTools FP7 Marie Curie Initial Training Network (project 289754 ), and The Lisa and David Pulver Family Foundation (B.D.). E.M. is the Arthur Gutterman Family Chair for Stem Cell Research. This work was partially supported by a generous gift from Arthur Gutterman to E.M. and B.D.
Funders | Funder number |
---|---|
Israel Ministry of Industry | |
Lisa and David Pulver Family Foundation | |
NIH-NIDDK | |
Sagol Center for Regenerative Medicine , School of Medicine , Tel Aviv University | |
Sagol Center for Regenerative Medicine, School of Medicine, Tel Aviv University | |
National Institutes of Health | |
National Institute of Diabetes and Digestive and Kidney Diseases | DK076169 |
Seventh Framework Programme | 289754 |
Israel Science Foundation | 2071/17, 910/11 |
Keywords
- CKD
- cell therapy
- chronic kidney disease
- dedifferentiation
- kidney organoid
- kidney progenitor
- kidney regeneration
- kidney spheroid
- long-term expansion
- redifferentiation
- reprogramming
- tubuloid